Control arises because activation, inactivation, and membrane cycling are regulated as connected but distinct events. GEF activity can promote signaling in a particular cellular location, while GAP activity limits its duration by accelerating hydrolysis. GDI-mediated redistribution adds another layer, helping determine where an inactive GTPase can become available for reuse.
Lipid modification favors association with membranes, but inactive GTPases must also move through the cell during repeated signaling cycles. GDIs bind these inactive proteins and regulate their solubility, supporting release from and return to membranes. This cycling helps connect the biochemical nucleotide state of a GTPase with its cellular location.
The outcome reflects the relative influence of nucleotide exchange and hydrolysis control. GEFs favor replacement of GDP with GTP, whereas GAPs accelerate the reaction that restores the GDP-bound state. Because these activities can be spatially and temporally regulated, cells can restrict signaling to appropriate locations and limit its duration.
GEFs primarily control nucleotide exchange, GAPs control the rate of GTP hydrolysis, and GDIs control the handling and movement of inactive, often lipid-modified GTPases. Their functions are complementary rather than interchangeable. Studying them together is therefore necessary to explain both the signaling state of a GTPase and its intracellular distribution.
This regulatory system provides a framework for interpreting cell growth, movement, cytoskeletal organization, and vesicle trafficking. Changes in exchange, hydrolysis, or membrane cycling can alter where signaling occurs and how long it persists. Consequently, examining these regulators helps connect molecular switch behavior with broader changes in cell organization and transport.
Disrupted control of small GTPases can interfere with signaling processes that influence cell growth and movement, making regulatory imbalance relevant to cancer biology. Examining GEF, GAP, and GDI activities can help researchers relate abnormal GTPase regulation to altered intracellular signaling rather than viewing the GTPase itself in isolation.